Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer

CONTEXT: Five to 10% of patients with differentiated thyroid cancers (DTC) develop invasive and/or distant metastatic disease that is marginally improved with standard therapies. Prognosis is poor for patients with anaplastic thyroid cancer, with a median survival of 3–5 months. We suggest that a pa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Endocrinol Metab
Main Authors: Bastman, Jill J., Serracino, Hilary S., Zhu, Yuwen, Koenig, Michelle R., Mateescu, Valerica, Sams, Sharon B., Davies, Kurtis D., Raeburn, Christopher D., McIntyre, Robert C., Haugen, Bryan R., French, Jena D.
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2016
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929840/
https://ncbi.nlm.nih.gov/pubmed/27045886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-4227
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares